980 reports of this reaction
5.2% of all CLOBETASOL PROPIONATE OINTMENT USP, 0.05% reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, manufactured by Encube Ethicals, Inc.. There are 980 FDA adverse event reports linking CLOBETASOL PROPIONATE OINTMENT USP, 0.05% to DRUG INEFFECTIVE. This represents approximately 5.2% of all 18,702 adverse event reports for this drug.
Patients taking CLOBETASOL PROPIONATE OINTMENT USP, 0.05% who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among CLOBETASOL PROPIONATE OINTMENT USP, 0.05% users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for CLOBETASOL PROPIONATE OINTMENT USP, 0.05%:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 980 FDA reports for CLOBETASOL PROPIONATE OINTMENT USP, 0.05%. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 5.2% of all adverse event reports for CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.